Glaxosmithkline Share News (GSK)

US stocks weekly: Fireworks

Semiconductor index up nearly 2% ** Financials firm 2.4%. Big banks rise after Fed stress test success, clearing path for dividend hikes, share buybacks

UK stocks stabilise a day after selloff on fiscal concerns

FTSE 100 rises 0.6%, FTSE 250 adds 1.2%

*

LONDON MARKET CLOSE: Pound climbs, bond yields ease as PM backs Reeves

(Alliance News) - The FTSE 100 and sterling rallied, while the bond market calmed on Thursday as Keir Starmer supported his chancellor, reassuring markets that a change at the Treasury wasn't on the cards.

UK dividends calendar - next 7 days

UK's midcaps record best quarter in more than four years, blue-chip index down

FTSE 100 down 0.4%, FTSE 250 falls 0.4%

*

LONDON BROKER RATINGS: Babcock International price targets raised

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

US senator probes GSK's halt of children's asthma inhaler

Hassan says decision reduces access for low-income patients

*

Bharat, GSK to halve price of malaria vaccine by 2028

Price to be cut to below $5 per dose by 2028

*

Bharat, GSK to halve price of malaria vaccine by 2028

LONDON, June 25 (Reuters) - Drugmakers Bharat Biotech and GSK will cut the price of their malaria vaccine to $5 per dose by 2028, more than halving its current cost, they said on Wednesday.

EMA accepts marketing authorisation application for GSK's linerixibat

(Sharecast News) - GSK said on Monday that the European Medicines Agency has accepted its marketing authorisation application for linerixibat, an investigational treatment for cholestatic pruritus in patients with primary biliary cholangitis (PBC).

GSK drug to treat itch caused by liver disease accepted for EU review

(Alliance News) - GSK PLC on Monday said linerixibat has been accepted for review by the European Medicines Agency for the treatment of intense itching caused by a rare autoimmune liver disease.

UK's FTSE 100 sees first weekly fall in six; Middle East tensions in focus

FTSE 100 down 0.2%, FTSE 250 adds 0.4%

*

LONDON MARKET CLOSE: FTSE 100 underperforms Europe despite Iran talks

(Alliance News) - London's FTSE 100 faded into the close on Friday, ending lower, as weak retail sales data and falls in heavyweight oil and drug stocks offset hopes for progress in the Israel-Iran conflict.

Japan accepts GSK application for expanded use of RSV vaccine Arexvy

(Alliance News) - GSK PLC on Friday announced that Japan has accepted a regulatory application to expand the use of its respiratory syncytial virus [RSV] vaccine Arexvy.

GSK hoping to expand Arexvy usage in Japan

(Sharecast News) - Japanese regulators have accepted GSK's application to expand the use of its RSV vaccine, Arexvy, to the entire adult population.